Статья

Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease

R. Inciardi, S. Solomon, P. Ridker, M. Metra,
2020

Acute respiratory failure associated with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS‐CoV‐2), has rapidly spread worldwide and presents critical challenges for the public health and medical communities. The World Health Organization (WHO) has declared SARS‐CoV‐2 a public health emergency of international concern, with a global estimate of over 7 million human infections and more than 400000 deaths worldwide as of June 12, 2020. A 2020 report by the China Medical Treatment Expert Group for Coronavirus disease 2010 (COVID‐19) (2) showed that the clinical spectrum of the viral infection is dominated by fever (up to 88.7% of patients during hospitalization) and cough (67.8% of patients) followed by symptoms such as headache, fatigue, or shortness of breath.

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2020-07-17

Метаданные

Об авторах
  • R. Inciardi
    Institute of Cardiology Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Italy
  • S. Solomon
    Cardiovascular Division Brigham and Women’s Hospital, and Harvard Medical School Boston MA
  • P. Ridker
    Division of Preventive Medicine Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital, and Harvard Medical School Boston MA
  • M. Metra
    Institute of Cardiology Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Italy
Название журнала
  • Journal of the American Heart Association
Том
  • 9
Выпуск
  • 16
Страницы
  • e017756
Издатель
  • Wolters Kluwer
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions